The invention encompasses the novel compound A, 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one, pharmaceutical compositions and use of the compound in the preparation of medicaments for the treatment of cyclooxygenase-2 mediated diseases.
该发明涵盖了新型化合物A,即2-(3,5-二
氟苯基)-3-(4-(甲磺基)苯基)-2-
环戊烯-1-酮,以及该化合物在制备用于治疗环氧合酶-2介导的疾病的药物中的应用。